Illumina has a conensus rating of Moderate Buy which is based on 7 buy ratings, 5 hold ratings and 3 sell ratings. The average price target. Stock Quote: NASDAQ: ILMN. Day's Open. Volume. 1,, Intraday Nasdaq Dow Other. Reinvest Dividends. Investment. Analyst Coverage. The. The current price of ILMN is USD — it has decreased by −% in the past 24 hours. Watch Illumina, Inc. stock price performance more closely on the. Wall Street Thinks Illumina Stock Will Rise 27% in 1 Year. Here's Why That Probably Won't Happen. Alex Carchidi | Aug 21, Its core revenue won't grow, and. Given that Illumina has a price to earning of X, we strongly advise you to confirm Illumina market performance and probability of bankruptcy to ensure the.
Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9%. According to 20 analysts, the average rating for ILMN stock is "Buy." The month stock price forecast is $, which is an increase of % from the. Is Illumina stock A Buy? Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying. The latest consensus rating for Illumina is "Hold". This is the average recommendation of 31 analysts: 0 strong sell, 2 sell, 14 hold, 7 buy, 8 strong buy. In. Consensus Rating · Buy ; Highest Price Target · $ ; Lowest Price Target · $ ; Consensus Price Target · $ View Illumina, Inc. ILMN stock quote prices, financial information, real analyst rating. buy; hold; sell. We're sorry, but this information is. Based on 23 Wall Street analysts who have issued ratings for Illumina in the last 12 months, the stock has a consensus rating of "Moderate Buy. The Illumina stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell. Should I buy Illumina (ILMN)? Use the Zacks Rank and Style Scores to find out is ILMN is right for your portfolio. Upgrading stock to BUY from HOLD. Illumina Inc., based in San Diego Illumina also sells microarrays (9% of sales) that enable lower-cost. The average one-year price target for Illumina, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price target is.
Analyst Ratings. The average analyst rating for Illumina stock from 20 stock analysts is "Buy". This means that analysts believe this stock is likely to. Valuation metrics show that Illumina, Inc. may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health. Learn more about whether Illumina Inc is a good stock to buy or sell based on recent news as well as its key financial metrics. Based on the Illumina stock forecast, it's now a good time to buy ILMN stock because it's trading % below our forecast, and it could be undervalued. Analysts' consensus rating of "Moderate Buy" and an average price target of $ suggest a positive outlook for the company. Cons. Investors should be. View the real-time ILMN price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees. Illumina currently has an average brokerage recommendation (ABR) of on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual. Over the next 52 weeks, Illumina has on average historically risen by % based on the past 24 years of stock performance. Illumina Stock Rating. Buy. Illumina, Inc.'s stock symbol is ILMN and currently trades under NASDAQ. It's current price per share is approximately $ What are your Illumina, Inc. .
Price targets go from $ to $ The majority of stock analysts believe ILMN is a buy. Please note analyst price targets are not guaranteed and could be. Out of 14 analysts, 6 (%) are recommending ILMN as a Strong Buy, 3 (%) are recommending ILMN as a Buy, 5 (%) are recommending ILMN as a Hold, 0. Illumina Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Illumina Inc ILMN:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date09/05/23 · 52 Week Low · 52 Week Low. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. ILMN will report
Wall Street Thinks Illumina Stock Will Rise 27% in 1 Year. Here's Why That Probably Won't Happen. Its core revenue won't grow, and that's not even its biggest. Stock Quote: NASDAQ: ILMN. Day's Open. Volume. 1,, Intraday Nasdaq Dow Other. Reinvest Dividends. Investment. Analyst Coverage. The. View Illumina, Inc. ILMN stock quote prices, financial information, real analyst rating. buy; hold; sell. We're sorry, but this information is. Buy. Overweight. 0. 1. 1. Hold. Underweight. 1. 1. 1. Sell. 1. 0. 0. ConsensusHoldBuyBuy. Stock Price Target. High, $ Low. Investors are encouraged to consult with their financial advisors regarding the specific implications of buying or selling Illumina common stock on or before. ILMN / Illumina, Inc. (NasdaqGS) - Forecast, Price Target, Estimates, Predictions ; Projected Stock Price. $ ↑%. Estimated share price by August Find out which Guru investors are buying and selling Illumina Inc (ILMN) today. Get the latest info and news about ILMN stock at baskcash.site Learn more about whether Illumina Inc is a good stock to buy or sell based on recent news as well as its key financial metrics. Illumina to Sell Grail. It's Giving Up on Its Biotech Antitrust Battle. Dec Buy Illumina Stock. The Biotech Is Lowering the Cost of Gene Sequencing. View Illumina, Inc. ILMN stock quote prices, financial information, real-time forecasts, and company news from CNN. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. ILMN will report Consensus Rating · Buy ; Highest Price Target · $ ; Lowest Price Target · $ ; Consensus Price Target · $ Over the next 52 weeks, Illumina has on average historically risen by 22% based on the past 24 years of stock performance. Illumina Stock Rating. Sell. View the real-time ILMN price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees. The average analyst rating for Illumina stock from 20 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9%. Based on 23 Wall Street analysts who have issued ratings for Illumina in the last 12 months, the stock has a consensus rating of "Moderate Buy. The latest consensus rating for Illumina is "Hold". This is the average recommendation of 31 analysts: 0 strong sell, 2 sell, 14 hold, 7 buy, 8 strong buy. In. Given that Illumina has a price to earning of X, we strongly advise you to confirm Illumina market performance and probability of bankruptcy to ensure the. Illumina (ILMN) - Develops integrated systems for the large-scale analysis of genetic variation and biological function. Analyst Ratings. The average analyst rating for Illumina stock from 20 stock analysts is "Buy". This means that analysts believe this stock is likely to. View analyst opinion as to whether the stock is a strong buy, strong sell or hold, based on analyst Month ILMN price targets. Created with Highcharts Stocks; Illumina. ILMN. Buy Illumina (ILMN) Stock. See ILMN stock price and Buy/Sell Illumina. Discuss news and analysts' price predictions with the investor. Buy. Overweight. 0. 1. 1. Hold. Underweight. 1. 1. 1. Sell. 1. 0. 0. ConsensusHoldBuyBuy. Stock Price Target. High, $ Low. Illumina currently has an average brokerage recommendation (ABR) of on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual. View the real-time ILMN price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees. The current price of ILMN is USD — it has increased by % in the past 24 hours. Watch Illumina, Inc. stock price performance more closely on the chart. Illumina, Inc. (ILMN) currently has an average brokerage recommendation (ABR) of on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the. Out of 14 analysts, 6 (%) are recommending ILMN as a Strong Buy, 3 (%) are recommending ILMN as a Buy, 5 (%) are recommending ILMN as a Hold, 0. The latest Illumina stock prices, stock quotes, news, and ILMN history to help you invest and trade smarter.
Illumina Inc ILMN:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date01/31/24 · 52 Week Low · 52 Week Low. Illumina Inc. ILMN (U.S.: Nasdaq). AT CLOSE PM EDT 09/13/ $USD; %. Volume1,, AFTER HOURS PM EDT 09/13/ What happened to Illumina's price movement after its last earnings report?